$1.31
-0.03-2.24%
At close: -
$1.39
0.086.11%
After Hours: Nov 15, 4:14 PM EDT
Comments
Loading...
NextCure (NXTC) Forecast
NewsEarningsNextCure (NXTC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestNextCure (NASDAQ:NXTC) Stock Quotes, Forecast and News Summary
NextCure Stock (NASDAQ: NXTC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy NextCure (NXTC) stock?
You can purchase shares of NextCure (NASDAQ:NXTC) through any online brokerage.
Who are NextCure (NXTC) competitors?
Other companies in NextCure’s space includes: Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS) and CARISMA Therapeutics (NASDAQ:CARM).
What is the forecast, or price target, for NextCure (NXTC) stock?
NextCure has a consensus price target of $7.25.
What is the current price for NextCure (NXTC)?
The stock price for NextCure (NASDAQ: NXTC) is $1.39 last updated November 15, 2024 at 4:14 PM EST.
Does NextCure (NXTC) pay a dividend?
There are no upcoming dividends for NextCure.
When is NextCure (NASDAQ:NXTC) reporting earnings?
NextCure’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is NextCure (NXTC) going to split?
There is no upcoming split for NextCure.
What sector and industry does NextCure (NXTC) operate in?
NextCure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.